We have found that there is a definite effect of the alpha-2-agonist, clonidine, on gastric motor and sensory function. The goal is to apply clonidine in a clinical area in an attempt to restore normal accommodation response and reduce gastric symptoms such as dyspepsia and bloating. This study led to an NIH RO3 grant application.
Showing the most recent 10 out of 1267 publications